Stock ASTRAZEN ASTRAZENECA PHARMA INDIA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Insiders AstraZeneca Pharma India Limited

Equities

ASTRAZEN

INE203A01020

Delayed Bombay S.E.
Other stock markets
 12:28:21 2024-04-29 am EDT 		5-day change 1st Jan Change
5,456 INR +0.75% Intraday chart for AstraZeneca Pharma India Limited +4.56% -1.16%
Apr. 08 AstraZeneca Pharma India Limited Approves Appointment of Bhavana Agrawal as Director and Whole Time Director CI
Mar. 25 AstraZeneca Pharma India Limited Appoints Vinay Sharma as Business Unit Head - Rare Disease, Effective July 1, 2024 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
AstraZeneca Pharma India Limited Approves Appointment of Bhavana Agrawal as Director and Whole Time Director
CI
AstraZeneca Pharma India Limited Appoints Vinay Sharma as Business Unit Head - Rare Disease, Effective July 1, 2024
CI
Astrazeneca Pharma India Limited Announces Board Changes
CI
AstraZeneca Pharma India Limited Announces Board Changes
CI
AstraZeneca Pharma India Limited Announces Directorate Appointments
CI
Astrazeneca Pharma India Limited Appoints Hooi-Bien Chuah as Additional Director (Non-Executive)
CI
Astrazeneca Pharma India Limited Announces Retirement of Rajesh Marwaha as Whole-Time Director
CI
AstraZeneca Pharma India Limited Appoints Praveen Akkinepally as the Business Unit Head ­ Oncology with Effect from November 1, 2023
CI
AstraZeneca Pharma India Limited Announces Executive Changes
CI
Astrazeneca Pharma India Names CFO
MT
AstraZeneca Pharma India Limited Announces Retirement of Mr. Rajesh Marwaha from the Office of Whole-Time Director, Effective September 30, 2023
CI
Astrazeneca Pharma India Appoints Managing Director
MT
Astrazeneca Pharma India Limited Announces Resignation of Gagandeep Singh Bedi as Director, Effective December 31, 2022
CI
AstraZeneca Pharma India Limited Announces Resignation of Gagandeep Singh Bedi as Managing Director, Effective December 31, 2022
CI
AstraZeneca Pharma India Limited Appoints Sanjeev Panchal as Country President
CI
Astrazeneca Pharma India Limited Appoints Sanjeev Panchal as Managing Director
CI
Astrazeneca Pharma India Limited Appoints Shilpa Shridhar Divekar, as an Independent Director
CI
AstraZeneca Pharma India Limited Announces Executive Changes
CI
Astrazeneca Pharma India Limited Announces Resignation of Kimsuka Narsimhan as Independent Director, At the Close of Business Hours on February 1, 2022
CI
AstraZeneca Pharma India Limited Appoints Shilpa Shridhar Divekar as Additional Director (Non-Executive & Independent) of the Company
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ASTRAZEN Stock
  4. News AstraZeneca Pharma India Limited
  5. Insiders